Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
47.4M
-
Shares change
-
-363K
-
Total reported value, excl. options
-
$1.55B
-
Value change
-
+$9.88M
-
Number of buys
-
48
-
Number of sells
-
-29
-
Price
-
$32.67
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q3 2018
102 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q3 2018.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.4M shares
of 49.8M outstanding shares and own 95.22% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (11.7M shares), BAUPOST GROUP LLC/MA (9.31M shares), FMR LLC (8.12M shares), BlackRock Inc. (3.83M shares), Vanguard Group Inc (3.67M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.6M shares), Cormorant Asset Management, LP (1.1M shares), STATE STREET CORP (884K shares), NORGES BANK (839K shares), and Consonance Capital Management LP (732K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.